Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 67 entries
Sorted by: Best Match Show Resources per page
Homozygosity mapping and sequencing identify two genes that might contribute to pointing behavior in hunting dogs.

Canine genetics and epidemiology

Akkad DA, Gerding WM, Gasser RB, Epplen JT.
PMID: 26401333
Canine Genet Epidemiol. 2015 Apr 18;2:5. doi: 10.1186/s40575-015-0018-5. eCollection 2015.

BACKGROUND: The domestic dog represents an important model for studying the genetics of behavior. In spite of technological advances in genomics and phenomics, the genetic basis of most specific canine behaviors is largely unknown. Some breeds of hunting dogs...

Cite
Akkad DA, Gerding WM, Gasser RB, et al. Homozygosity mapping and sequencing identify two genes that might contribute to pointing behavior in hunting dogs. Canine Genet Epidemiol. 2015;2:5doi: 10.1186/s40575-015-0018-5.
Akkad, D. A., Gerding, W. M., Gasser, R. B., & Epplen, J. T. (2015). Homozygosity mapping and sequencing identify two genes that might contribute to pointing behavior in hunting dogs. Canine genetics and epidemiology, 25. https://doi.org/10.1186/s40575-015-0018-5
Akkad, Denis A, et al. "Homozygosity mapping and sequencing identify two genes that might contribute to pointing behavior in hunting dogs." Canine genetics and epidemiology vol. 2 (2015): 5. doi: https://doi.org/10.1186/s40575-015-0018-5
Akkad DA, Gerding WM, Gasser RB, Epplen JT. Homozygosity mapping and sequencing identify two genes that might contribute to pointing behavior in hunting dogs. Canine Genet Epidemiol. 2015 Apr 18;2:5. doi: 10.1186/s40575-015-0018-5. eCollection 2015. PMID: 26401333; PMCID: PMC4579392.
Copy Download .nbib Format: NLM
Correction for Cairns et al., "Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages".

Journal of clinical microbiology

Cairns MD, Preston MD, Hall CL, Gerding DN, Hawkey PM, Kato H, Kim H, Kuijper EJ, Lawley TD, Pituch H, Reid S, Kullin B, Riley TV, Solomon K, Tsai PJ, Weese JS, Stabler RA, Wren BW.
PMID: 28536162
J Clin Microbiol. 2017 Jun;55(6):1971. doi: 10.1128/JCM.00487-17.

No abstract available.

Cite
Cairns MD, Preston MD, Hall CL, et al. Correction for Cairns et al., "Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages". J Clin Microbiol. 2017;55(6):1971doi: 10.1128/JCM.00487-17.
Cairns, M. D., Preston, M. D., Hall, C. L., Gerding, D. N., Hawkey, P. M., Kato, H., Kim, H., Kuijper, E. J., Lawley, T. D., Pituch, H., Reid, S., Kullin, B., Riley, T. V., Solomon, K., Tsai, P. J., Weese, J. S., Stabler, R. A., & Wren, B. W. (2017). Correction for Cairns et al., "Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages". Journal of clinical microbiology, 55(6), 1971. https://doi.org/10.1128/JCM.00487-17
Cairns, M D, et al. "Correction for Cairns et al., "Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages"." Journal of clinical microbiology vol. 55,6 (2017): 1971. doi: https://doi.org/10.1128/JCM.00487-17
Cairns MD, Preston MD, Hall CL, Gerding DN, Hawkey PM, Kato H, Kim H, Kuijper EJ, Lawley TD, Pituch H, Reid S, Kullin B, Riley TV, Solomon K, Tsai PJ, Weese JS, Stabler RA, Wren BW. Correction for Cairns et al., "Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages". J Clin Microbiol. 2017 Jun;55(6):1971. doi: 10.1128/JCM.00487-17. PMID: 28536162; PMCID: PMC5442559.
Copy Download .nbib Format: NLM
The 16PF Related to the Five-Factor Model of Personality: Multiple-Indicator Measurement versus the A Priori Scales.

Multivariate behavioral research

Gerbing DW, Tuley MR.
PMID: 26828255
Multivariate Behav Res. 1991 Apr 01;26(2):271-89. doi: 10.1207/s15327906mbr2602_5.

This article examines the Sixteen Personality Factor Inventory (16PF; Cattell, Eber, & Tatsuoka, 1970) in terms of recent methodological and substantive developments: restricted (confirmatory) factor analysis and the five-factor model of personality as operationalized by the NEO-PI (NEO Personality...

Cite
Gerbing DW, Tuley MR. The 16PF Related to the Five-Factor Model of Personality: Multiple-Indicator Measurement versus the A Priori Scales. Multivariate Behav Res. 1991;26(2):271-89doi: 10.1207/s15327906mbr2602_5.
Gerbing, D. W., & Tuley, M. R. (1991). The 16PF Related to the Five-Factor Model of Personality: Multiple-Indicator Measurement versus the A Priori Scales. Multivariate behavioral research, 26(2), 271-89. https://doi.org/10.1207/s15327906mbr2602_5
Gerbing, D W, and Tuley, M R. "The 16PF Related to the Five-Factor Model of Personality: Multiple-Indicator Measurement versus the A Priori Scales." Multivariate behavioral research vol. 26,2 (1991): 271-89. doi: https://doi.org/10.1207/s15327906mbr2602_5
Gerbing DW, Tuley MR. The 16PF Related to the Five-Factor Model of Personality: Multiple-Indicator Measurement versus the A Priori Scales. Multivariate Behav Res. 1991 Apr 01;26(2):271-89. doi: 10.1207/s15327906mbr2602_5. PMID: 26828255.
Copy Download .nbib Format: NLM
Assessing genetic diversity in a sugarcane germplasm collection using an automated AFLP analysis.

Genetica

Besse P, Taylor G, Carroll B, Berding N, Burner D, McIntyre CL.
PMID: 16220373
Genetica. 1998 Oct;104(2):143-53. doi: 10.1023/A:1003436403678.

An assessment of genetic diversity within and between Saccharum, Old World Erianthus sect. Ripidium, and North American E.giganteus (S.giganteum) was conducted using Amplified Fragment Length Polymorphism (AFLP(TM)) markers. An automated gel scoring system (GelCompar(TM)) was successfully used to analyse...

Cite
Besse P, Taylor G, Carroll B, et al. Assessing genetic diversity in a sugarcane germplasm collection using an automated AFLP analysis. Genetica. 1998;104(2):143-53doi: 10.1023/A:1003436403678.
Besse, P., Taylor, G., Carroll, B., Berding, N., Burner, D., & McIntyre, C. L. (1998). Assessing genetic diversity in a sugarcane germplasm collection using an automated AFLP analysis. Genetica, 104(2), 143-53. https://doi.org/10.1023/A:1003436403678
Besse, P, et al. "Assessing genetic diversity in a sugarcane germplasm collection using an automated AFLP analysis." Genetica vol. 104,2 (1998): 143-53. doi: https://doi.org/10.1023/A:1003436403678
Besse P, Taylor G, Carroll B, Berding N, Burner D, McIntyre CL. Assessing genetic diversity in a sugarcane germplasm collection using an automated AFLP analysis. Genetica. 1998 Oct;104(2):143-53. doi: 10.1023/A:1003436403678. PMID: 16220373.
Copy Download .nbib Format: NLM
Auxin Oxidase and Growth Control in Tissue Cultures of Ephedra.

Plant physiology

Straus J, Gerding RK.
PMID: 16655842
Plant Physiol. 1963 Nov;38(6):621-7. doi: 10.1104/pp.38.6.621.

No abstract available.

Cite
Straus J, Gerding RK. Auxin Oxidase and Growth Control in Tissue Cultures of Ephedra. Plant Physiol. 1963;38(6):621-7doi: 10.1104/pp.38.6.621.
Straus, J., & Gerding, R. K. (1963). Auxin Oxidase and Growth Control in Tissue Cultures of Ephedra. Plant physiology, 38(6), 621-7. https://doi.org/10.1104/pp.38.6.621
Straus, J, and Gerding, R K. "Auxin Oxidase and Growth Control in Tissue Cultures of Ephedra." Plant physiology vol. 38,6 (1963): 621-7. doi: https://doi.org/10.1104/pp.38.6.621
Straus J, Gerding RK. Auxin Oxidase and Growth Control in Tissue Cultures of Ephedra. Plant Physiol. 1963 Nov;38(6):621-7. doi: 10.1104/pp.38.6.621. PMID: 16655842; PMCID: PMC549985.
Copy Download .nbib Format: NLM
The 12 points of the dental law.

CDS review

Gerding J.
PMID: 22774369
CDS Rev. 2012 May-Jun;105(3):6.

No abstract available.

Cite
Gerding J. The 12 points of the dental law. CDS Rev. 2012;105(3):6
Gerding, J. (2012). The 12 points of the dental law. CDS review, 105(3), 6.
Gerding, John. "The 12 points of the dental law." CDS review vol. 105,3 (2012): 6.
Gerding J. The 12 points of the dental law. CDS Rev. 2012 May-Jun;105(3):6. PMID: 22774369.
Copy Download .nbib Format: NLM
Nematodes in Fresh Market Fish of the Washington, D.C. Area.

Journal of food protection

Jackson GJ, Bier JW, Payne WL, Gerding TA, Knollenberg WG.
PMID: 30795118
J Food Prot. 1978 Aug;41(8):613-620. doi: 10.4315/0362-028X-41.8.613.

For this study 1,010 fresh whole fish belonging to 14 families, 20 genera, and 23 species were bought in retail markets of the Washington, D.C. area. Most of the fish had been caught in Chesapeake Bay and adjacent waters....

Cite
Jackson GJ, Bier JW, Payne WL, et al. Nematodes in Fresh Market Fish of the Washington, D.C. Area. J Food Prot. 1978;41(8):613-620doi: 10.4315/0362-028X-41.8.613.
Jackson, G. J., Bier, J. W., Payne, W. L., Gerding, T. A., & Knollenberg, W. G. (1978). Nematodes in Fresh Market Fish of the Washington, D.C. Area. Journal of food protection, 41(8), 613-620. https://doi.org/10.4315/0362-028X-41.8.613
Jackson, G J, et al. "Nematodes in Fresh Market Fish of the Washington, D.C. Area." Journal of food protection vol. 41,8 (1978): 613-620. doi: https://doi.org/10.4315/0362-028X-41.8.613
Jackson GJ, Bier JW, Payne WL, Gerding TA, Knollenberg WG. Nematodes in Fresh Market Fish of the Washington, D.C. Area. J Food Prot. 1978 Aug;41(8):613-620. doi: 10.4315/0362-028X-41.8.613. PMID: 30795118.
Copy Download .nbib Format: NLM
Neurodegeneration in the olfactory bulb and olfactory deficits in the .

IBRO reports

Schreiber S, Petrasch-Parwez E, Porrmann-Kelterbaum E, Förster E, Epplen JT, Gerding WM.
PMID: 30211337
IBRO Rep. 2018 Aug 24;5:43-53. doi: 10.1016/j.ibror.2018.08.004. eCollection 2018 Dec.

The

Cite
Schreiber S, Petrasch-Parwez E, Porrmann-Kelterbaum E, et al. Neurodegeneration in the olfactory bulb and olfactory deficits in the . IBRO Rep. 2018;5:43-53doi: 10.1016/j.ibror.2018.08.004.
Schreiber, S., Petrasch-Parwez, E., Porrmann-Kelterbaum, E., Förster, E., Epplen, J. T., & Gerding, W. M. (2018). Neurodegeneration in the olfactory bulb and olfactory deficits in the . IBRO reports, 543-53. https://doi.org/10.1016/j.ibror.2018.08.004
Schreiber, Sabrina, et al. "Neurodegeneration in the olfactory bulb and olfactory deficits in the ." IBRO reports vol. 5 (2018): 43-53. doi: https://doi.org/10.1016/j.ibror.2018.08.004
Schreiber S, Petrasch-Parwez E, Porrmann-Kelterbaum E, Förster E, Epplen JT, Gerding WM. Neurodegeneration in the olfactory bulb and olfactory deficits in the . IBRO Rep. 2018 Aug 24;5:43-53. doi: 10.1016/j.ibror.2018.08.004. eCollection 2018 Dec. PMID: 30211337; PMCID: PMC6132079.
Copy Download .nbib Format: NLM
The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis.

Molecular metabolism

Heida A, Gruben N, Catrysse L, Koehorst M, Koster M, Kloosterhuis NJ, Gerding A, Havinga R, Bloks VW, Bongiovanni L, Wolters JC, van Dijk T, van Loo G, de Bruin A, Kuipers F, Koonen DPY, van de Sluis B.
PMID: 34626855
Mol Metab. 2021 Oct 06;54:101349. doi: 10.1016/j.molmet.2021.101349. Epub 2021 Oct 06.

OBJECTIVE: Obesity-related chronic inflammation plays an important role in the development of Metabolic Associated Fatty Liver Disease (MAFLD). Although the contribution of the pro-inflammatory NF-κB signaling pathway to the progression from simple steatosis to non-alcoholic steatohepatitis (NASH) is well-established,...

Cite
Heida A, Gruben N, Catrysse L, et al. The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis. Mol Metab. 2021;54:101349doi: 10.1016/j.molmet.2021.101349.
Heida, A., Gruben, N., Catrysse, L., Koehorst, M., Koster, M., Kloosterhuis, N. J., Gerding, A., Havinga, R., Bloks, V. W., Bongiovanni, L., Wolters, J. C., van Dijk, T., van Loo, G., de Bruin, A., Kuipers, F., Koonen, D. P. Y., & van de Sluis, B. (2021). The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis. Molecular metabolism, 54101349. https://doi.org/10.1016/j.molmet.2021.101349
Heida, Andries, et al. "The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis." Molecular metabolism vol. 54 (2021): 101349. doi: https://doi.org/10.1016/j.molmet.2021.101349
Heida A, Gruben N, Catrysse L, Koehorst M, Koster M, Kloosterhuis NJ, Gerding A, Havinga R, Bloks VW, Bongiovanni L, Wolters JC, van Dijk T, van Loo G, de Bruin A, Kuipers F, Koonen DPY, van de Sluis B. The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis. Mol Metab. 2021 Oct 06;54:101349. doi: 10.1016/j.molmet.2021.101349. Epub 2021 Oct 06. PMID: 34626855; PMCID: PMC8581577.
Copy Download .nbib Format: NLM
Oral Immunotherapy With Human Secretory Immunoglobulin A Improves Survival in the Hamster Model of Clostridioides difficile Infection.

The Journal of infectious diseases

Chiari EF, Weiss W, Simon MR, Kiessig ST, Pulse M, Brown SC, Gerding HR, Mandago M, Gisch K, von Eichel-Streiber C.
PMID: 33588433
J Infect Dis. 2021 Oct 28;224(8):1394-1397. doi: 10.1093/infdis/jiab087.

Coadministration of human secretory IgA (sIgA) together with subtherapeutic vancomycin enhanced survival in the Clostridioides difficile infection (CDI) hamster model. Vancomycin (5 or 10 mg/kg × 5 days) plus healthy donor plasma sIgA/monomeric IgA (TID × 21 days) or...

Cite
Chiari EF, Weiss W, Simon MR, et al. Oral Immunotherapy With Human Secretory Immunoglobulin A Improves Survival in the Hamster Model of Clostridioides difficile Infection. J Infect Dis. 2021;224(8):1394-1397doi: 10.1093/infdis/jiab087.
Chiari, E. F., Weiss, W., Simon, M. R., Kiessig, S. T., Pulse, M., Brown, S. C., Gerding, H. R., Mandago, M., Gisch, K., & von Eichel-Streiber, C. (2021). Oral Immunotherapy With Human Secretory Immunoglobulin A Improves Survival in the Hamster Model of Clostridioides difficile Infection. The Journal of infectious diseases, 224(8), 1394-1397. https://doi.org/10.1093/infdis/jiab087
Chiari, Estelle F, et al. "Oral Immunotherapy With Human Secretory Immunoglobulin A Improves Survival in the Hamster Model of Clostridioides difficile Infection." The Journal of infectious diseases vol. 224,8 (2021): 1394-1397. doi: https://doi.org/10.1093/infdis/jiab087
Chiari EF, Weiss W, Simon MR, Kiessig ST, Pulse M, Brown SC, Gerding HR, Mandago M, Gisch K, von Eichel-Streiber C. Oral Immunotherapy With Human Secretory Immunoglobulin A Improves Survival in the Hamster Model of Clostridioides difficile Infection. J Infect Dis. 2021 Oct 28;224(8):1394-1397. doi: 10.1093/infdis/jiab087. PMID: 33588433; PMCID: PMC8557658.
Copy Download .nbib Format: NLM
Environmental Health Practice Challenges and Research Needs for U.S. Health Departments.

Environmental health perspectives

Brooks BW, Gerding JA, Landeen E, Bradley E, Callahan T, Cushing S, Hailu F, Hall N, Hatch T, Jurries S, Kalis MA, Kelly KR, Laco JP, Lemin N, McInnes C, Olsen G, Stratman R, White C, Wille S, Sarisky J.
PMID: 31799881
Environ Health Perspect. 2019 Dec;127(12):125001. doi: 10.1289/EHP5161. Epub 2019 Dec 04.

BACKGROUND: Environmental health (EH) professionals, one of the largest segments of the public health workforce, are responsible for delivery of essential environmental public health services. The challenges facing these professionals and research needs to improve EH practice are not...

Cite
Brooks BW, Gerding JA, Landeen E, et al. Environmental Health Practice Challenges and Research Needs for U.S. Health Departments. Environ Health Perspect. 2019;127(12):125001doi: 10.1289/EHP5161.
Brooks, B. W., Gerding, J. A., Landeen, E., Bradley, E., Callahan, T., Cushing, S., Hailu, F., Hall, N., Hatch, T., Jurries, S., Kalis, M. A., Kelly, K. R., Laco, J. P., Lemin, N., McInnes, C., Olsen, G., Stratman, R., White, C., Wille, S., & Sarisky, J. (2019). Environmental Health Practice Challenges and Research Needs for U.S. Health Departments. Environmental health perspectives, 127(12), 125001. https://doi.org/10.1289/EHP5161
Brooks, Bryan W, et al. "Environmental Health Practice Challenges and Research Needs for U.S. Health Departments." Environmental health perspectives vol. 127,12 (2019): 125001. doi: https://doi.org/10.1289/EHP5161
Brooks BW, Gerding JA, Landeen E, Bradley E, Callahan T, Cushing S, Hailu F, Hall N, Hatch T, Jurries S, Kalis MA, Kelly KR, Laco JP, Lemin N, McInnes C, Olsen G, Stratman R, White C, Wille S, Sarisky J. Environmental Health Practice Challenges and Research Needs for U.S. Health Departments. Environ Health Perspect. 2019 Dec;127(12):125001. doi: 10.1289/EHP5161. Epub 2019 Dec 04. PMID: 31799881; PMCID: PMC6957286.
Copy Download .nbib Format: NLM
Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of .

Open forum infectious diseases

Dubberke ER, Gerding DN, Kelly CP, Garey KW, Rahav G, Mosley A, Tipping R, Dorr MB.
PMID: 32523972
Open Forum Infect Dis. 2020 Jun 02;7(6):ofaa157. doi: 10.1093/ofid/ofaa157. eCollection 2020 Jun.

BACKGROUND: In phase 3 MODIFY I/II trials, bezlotoxumab significantly reduced recurrence of METHODS: In MODIFY I/II (NCT01241552/NCT01513239), participants received a single infusion of bezlotoxumab (10 mg/kg) or placebo during anti-CDI treatment. Using pooled data from MODIFY I/II, initial clinical...

Cite
Dubberke ER, Gerding DN, Kelly CP, et al. Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of . Open Forum Infect Dis. 2020;7(6):ofaa157doi: 10.1093/ofid/ofaa157.
Dubberke, E. R., Gerding, D. N., Kelly, C. P., Garey, K. W., Rahav, G., Mosley, A., Tipping, R., & Dorr, M. B. (2020). Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of . Open forum infectious diseases, 7(6), ofaa157. https://doi.org/10.1093/ofid/ofaa157
Dubberke, Erik R, et al. "Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of ." Open forum infectious diseases vol. 7,6 (2020): ofaa157. doi: https://doi.org/10.1093/ofid/ofaa157
Dubberke ER, Gerding DN, Kelly CP, Garey KW, Rahav G, Mosley A, Tipping R, Dorr MB. Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of . Open Forum Infect Dis. 2020 Jun 02;7(6):ofaa157. doi: 10.1093/ofid/ofaa157. eCollection 2020 Jun. PMID: 32523972; PMCID: PMC7264839.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 67 entries